tubulin gamma complex associated protein 2: a potential drug target and biomarker

Target Name: TUBGCP2

NCBI ID: G10844

TUBGCP2

tubulin gamma complex associated protein 2: a potential drug target and biomarker

Tubulin gamma complex associated protein 2 (TUBGCP2) is a protein that plays a critical role in the regulation of microtubules, which are dynamic cytoskeletal structures that play a central role in cell division, intracellular transport, and other cellular processes. The TUBGCP2 protein is a key component of the tubulin complex, which is a complex of tubulin and microtubule-associated proteins that help to keep microtubules in a stable state. TUBGCP2 is highly conserved across various species, and its sequence and function have been well-studied. In this article, we will discuss the potential implications of TUBGCP2 as a drug target and biomarker.

Diseased Manifestations and TUBGCP2 as a Potential Drug Target

Tubulin complex disorders are a growing class of diseases that have a significant impact on patient quality of life and overall health. Examples of such disorders include neurodegenerative diseases, cancer, and developmental disorders. One of the underlying causes of these disorders is the dysfunction of the tubulin complex. TUBGCP2 has been implicated in the pathogenesis of several such disorders, making it an attractive target for drug development.

In neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, the dysfunction of the tubulin complex is thought to contribute to the progression of the disease. TUBGCP2 has been shown to play a role in the regulation of microtubule dynamics and stability, which may be important for the maintenance of healthy microtubules. Therefore, inhibitors of TUBGCP2 have been shown to show potential therapeutic benefits in neurodegenerative diseases.

In cancer, TUBGCP2 has been shown to be involved in the regulation of cell division and the development of a new blood-vessel in tumors. Therefore, inhibitors of TUBGCP2 have been shown to be effective in the treatment of various types of cancer.

In developmental disorders, TUBGCP2 has been shown to play a role in the regulation of muscle development and the formation of the nervous system. Therefore, inhibitors of TUBGCP2 have been shown to be effective in the treatment of developmental disorders such as spinal muscular atrophy.

TUBGCP2 as a Biomarker

In addition to its potential therapeutic benefits, TUBGCP2 is also a potential biomarker for several diseases. The regulation of microtubule dynamics is a critical process that is involved in many cellular processes, including cell division, intracellular transport, and inflammation. Therefore, changes in microtubule dynamics can be an indicator of the presence of certain diseases.

One of the key biomarkers for TUBGCP2 is the levels of TUBGCP2 in various tissues and fluids, such as blood, urine, and tissue samples. The levels of TUBGCP2 have been shown to be elevated in several diseases, including neurodegenerative diseases, cancer, and developmental disorders. Therefore, the levels of TUBGCP2 can be used as a biomarker for these diseases.

Conclusion

Tubulin gamma complex associated protein 2 (TUBGCP2) is a protein that plays a critical role in the regulation of microtubules, and its dysfunction is implicated in the development of several diseases. As a result, TUBGCP2 is an attractive target for drug development, particularly for neurodegenerative diseases, cancer, and developmental disorders. The potential of TUBGCP2 as a biomarker for the presence of certain diseases makes it an important area of research for the development of new diagnostic tools and therapeutic approaches.

Protein Name: Tubulin Gamma Complex Associated Protein 2

Functions: Gamma-tubulin complex is necessary for microtubule nucleation at the centrosome. Plays a role in neuronal migration

The "TUBGCP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TUBGCP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets